Greenland Mines (NASDAQ: GRML) announced that independent consultant SLR Consulting (Canada) Ltd. has completed the first U.S. Securities and Exchange Commission S-K 1300-compliant Technical Report Summary for the Skaergaard project in southeast Greenland. The report features an updated 2026 Mineral Resource Estimate effective July 3, 2026, which increased indicated contained palladium equivalent (“PdEq”) metal by 31% to 15.0 million ounces, boosted indicated grade by 36% to 3.04 g/t PdEq, and raised inferred contained PdEq metal by 24% to 17.49 million ounces compared with the project’s 2022 resource estimate.
The company said the upgraded resource reflects improved geological modeling and updated metal price assumptions, including gold at $3,500 per ounce, while providing the regulatory foundation to advance toward an Initial Assessment under S-K 1300. The S-K 1300 standard, adopted by the SEC in 2018, requires mining companies to disclose mineral resources and reserves using a consistent framework, enhancing transparency for investors. This compliance positions Greenland Mines to potentially attract more institutional investment as the project moves toward feasibility studies.
Greenland Mines also noted that its 2026 field program is underway with drilling, bulk sampling, engineering, environmental and geotechnical work designed to support evaluation of both open-pit and underground mining scenarios at the Skaergaard project. The project is located in southeast Greenland, a region with significant mineral potential but also logistical and regulatory challenges. The updated resource estimate underscores the project's scale, with total contained PdEq exceeding 32 million ounces across indicated and inferred categories.
The importance of this announcement lies in the strategic value of palladium and other platinum group metals (PGMs) for automotive catalytic converters, hydrogen fuel cells, and electronics. With global supply constraints and rising demand for clean energy technologies, the Skaergaard project could become a significant non-Russian source of PGMs. Additionally, Greenland Mines operates a biotech division focused on Klotho’s KLTO‑202 primary indication for ALS, but the mining division remains the primary driver of market interest.
For more details, the full press release is available at https://ibn.fm/qqEBp. Further updates on GRML can be found in the company’s newsroom at https://ibn.fm/GRML.
